FDA-wide inventory of property should be finished by end of April, Friedman tells hearing.
This article was originally published in The Tan Sheet
Executive Summary
FDA AGENCY-WIDE INVENTORY OF ACCOUNTABLE PROPERTY is expected to be complete by the end of April, agency Lead Deputy Commissioner Michael Friedman, MD, testified at an April 1 House Commerce/Oversight & Investigations Subcommittee hearing on FDA financial management issues. FDA is "nearing the end of the laborious process of reconciling the data gathered from each center with agency records," Friedman said. "The end result, which should be completed by the end of this month, will be a wall-to-wall inventory of all agency accountable property."